Second Medical Opinion

Your trusted source for evidence-based medical information, reviewed by healthcare professionals

✓ Medical Professional Reviewed ✓ Evidence-Based Content ✓ Regularly Updated

RYDAPT

RYDAPT

by

Description RYDAPT is a kinase inhibitor used to treat specific adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation. It is also indicated for the treatment of aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast … Read more